Il 6 inhibitor drugs

Interleukin-6 (IL-6) inhibitors: These drugs block the effects of IL-6, another protein that causes inflammation. Examples include tocilizumab (Actermra ) and sarilumab (Kevzara ). T-cell inhibitor: These drugs prevent your body s T-cells from killing healthy cells. An example of a T-cell inhibitor is abatacept (Orencia ).

Drugs targeting IL-6 can be roughly divided into direct inhibitors and IL-6 receptor inhibitors. The latter offer an advantage, as they have the capacity to also block other interleukins of the same family, such as IL-1, which also play an important role in the pathogenesis of RA [ 58 ].

The co-administration of medications known as proton pump inhibitors such as omeprazole Tocilizumab is the first approved drug in a class of IL-6 inhibitors.

Examples include anakinra (Kineret), canakinumab (Ilaris) and rilonacept (Arcalyst). Interleukin-6 (IL-6) inhibitors: These drugs block the effects of IL-6

Interleukin-6 (IL-6) inhibitors: These drugs block the effects of IL-6, another protein that causes inflammation. Examples include tocilizumab (Actermra ) and sarilumab (Kevzara ). T-cell inhibitor: These drugs prevent your body s T-cells from killing healthy cells. An example of a T-cell inhibitor is abatacept (Orencia ).

The co-administration of medications known as proton pump inhibitors such as omeprazole Tocilizumab is the first approved drug in a class of IL-6 inhibitors.

There are currently five TNF inhibitors FDA approved for the treatment of RA Tocilizumab is the first approved drug in a class of IL-6 inhibitors.

A TNF inhibitor is a drug that inhibits the physiologic response to TNF, a Among these drugs which are currently under development, the IL-6 inhibitor

Keywords: biological disease-modifying anti-rheumatic drugs, biologics, conventional disease-modifying anti-rheumatic drugs, hand osteoarthritis, hydroxychloroquine, IL-1 inhibitors, IL-6 inhibitors, methotrexate, osteoarthritis, TNF- inhibitors